The Application of Viruses to Biotechnology

Edited by
December 2021
306 pages
  • ISBN978-3-0365-2539-6 (Hardback)
  • ISBN978-3-0365-2538-9 (PDF)

This book is a reprint of the Special Issue The Application of Viruses to Biotechnology that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare

Viruses are microscopic agents that exist worldwide and are present in humans, animals, plants, and other living organisms in which they can cause devastating diseases. However, the advances of biotechnology and next-generation sequencing technologies have accelerated novel virus discovery, identification, sequencing, and manipulation, showing that they present unique characteristics that place them as valuable tools for a wide variety of biotechnological applications. Many applications of viruses have been used for agricultural purposes, namely concerning plant breeding and plant protection. Nevertheless, it is interesting to mention that plants have also many advantages to be used in vaccine production, such as the low cost and low risks they entail, showing once more the versatility of the use of viruses in biotechnology. Although it will obviously never be ignored that viruses are responsible for devastating diseases, it is clear that the more they are studied, the more possibilities they offer to us. They are now on the front line of the most revolutionizing techniques in several fields, providing advances that would not be possible without their existence. In this book there are presented studies that demonstrate the work developed using viruses in biotechnology. These studies were brought by experts that focus on the development and applications of many viruses in several fields, such as agriculture, the pharmaceutical industry, and medicine.

  • Hardback
© 2022 by the authors; CC BY-NC-ND license
Bacteriophage; Salmonella; biocontrol; comparative genomics; phage diversity; grapevine; apple latent spherical virus vector; virus-induced flowering; reduced generation time; breeding of grapevine; virus elimination; Newcastle disease virus; reverse genetics; vaccines; infectious diseases; cancer; porcine epidemic diarrhea virus; VLP; chemokines; pig; vaccine; SARS-CoV-2; COVID-19; phages; CRISPR; viruses; prevention; diagnosis; treatment; adeno-associated virus (AAV) vector; jaagsiekte sheep retrovirus (JSRV); LTR; enhancer; transduction; viral vaccines; infectious diseases; cancers; COVID-19 vaccines; self-replicating RNA vectors; DNA-based vaccines; RNA-based vaccines; plant virus; viroid; viral vector; virus-induced gene silencing (VIGS); CRISPR/Cas9; genome editing; carotenoid biosynthesis; vaccine; circular RNA; infectious bursal disease virus; immunization; recombinant Lactococcus lactis; variant strain; vaccine; baculovirus; insect cells; bacmid; Tn7; genome stability; protein expression; chikungunya virus; VLPs; bioreactor; CRISPR/Cas systems; viral vectors; gene editing; plant genome engineering; viral resistance; adeno-associated virus; AAV; cancer gene therapy; prophage; hydrothermal vent; Hypnocyclicus thermotrophus; lytic cassette; Escherichia coli; heterologous expression; codon optimization; codon harmonization; expression vectors; aspect ratio; VLPs; VNPs; TMV; PVX; CPMV; geminivirus; cancer; theranostics; CRISPR-cas9; adeno-associated virus; clodronate; macrophage; gene therapy; gene expression; gene therapy; nanotechnology; vaccines; viral vectors